Stephen Huang, MD
Dermatology · Golden, CONPI 1609032978
Payments from drug & device makers
Across 557 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Siemens Medical Solutions USA, Inc.$918
- Amgen$825
- LEO Pharma Inc.$732
- Sun Pharmaceutical Industries Inc.$723
- Sanofi$675
- plus $5K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 80 | $1,262 |
| Siemens Medical Solutions USA, Inc. | 10 | $918 |
| Amgen | 51 | $825 |
| LEO Pharma Inc. | 51 | $732 |
| Sun Pharmaceutical Industries Inc. | 51 | $723 |
| Sanofi | 30 | $675 |
| Galderma Laboratories, L.p. | 53 | $670 |
| Pfizer | 35 | $542 |
| Novartis | 20 | $417 |
| Johnson & Johnson | 19 | $407 |
| Regeneron Healthcare Solutions, Inc. | 10 | $304 |
| Arcutis Biotherapeutics, Inc. | 17 | $253 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 11 | $248 |
| E.r. Squibb & Sons, L.L.C. | 11 | $237 |
| Incyte Corporation | 9 | $215 |
| UCB, Inc. | 10 | $214 |
| EPI Health, LLC | 15 | $206 |
| Organon | 10 | $183 |
| VYNE Pharmaceuticals Inc. | 5 | $179 |
| Lilly USA, LLC | 7 | $175 |
| Dermavant Sciences, Inc. | 8 | $130 |
| Journey Medical Corporation | 7 | $122 |
| Bristol Myers Squibb | 6 | $106 |
| Almirall LLC | 5 | $103 |
| Boehringer Ingelheim | 5 | $99 |
| Verrica Pharmaceuticals Inc. | 4 | $76 |
| Dermira, Inc. | 4 | $61 |
| Aclaris Therapeutics, Inc. | 3 | $43 |
| Mayne Pharma Commercial LLC | 3 | $41 |
| Biofrontera Inc. | 2 | $37 |
| Mission Pharmacal Company | 2 | $27 |
| DUSA Pharmaceuticals, Inc. | 1 | $27 |
| Organogenesis Inc. | 1 | $21 |
| LNHC, Inc | 1 | $20 |
How this compares
$10,300 in reported general payments places this provider in the 85th percentile of 280 dermatology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Golden
- Scott WalterGolden$99K
- Kathleen SawadaGolden$60K
- Marcjonathan SerotaLittleton$3.2M
- Stanca BirleaAurora$1.9M
- James SwinehartDenver$931K
- Theodore AlkousakisAurora$880K
- Ammon LarsenLoveland$620K
- Victoria MossColorado Springs$473K
- James JensenCastle Rock$380K
- Cory DunnickAurora$366K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.